Latest News for: gips

Edit

Care for caregivers: GIPS Mental Health Summit focuses on student and staff support

The Grand Island Independent 05 Apr 2025
The event gathered district counselors and social workers alongside like-minded mental health providers and professionals from community organizations for a day of professional development, collaboration and decompression ... .
Edit

Ava Gips: Join national day of protest on April 5

The Recorder 02 Apr 2025
.
Edit

Vale to establish JV in Aliança Geração de Energia with GIP

SteelOrbis 02 Apr 2025
Vale will receive approximately US$1 billion in cash and hold a 30 percent stake in the joint venture, while GIP will hold the remaining 70 percent.
Edit

Soon at GIP mall: Mythology, sports, snow themed parks

Hindustan Times 01 Apr 2025
In a significant development for Noida’s entertainment landscape, the Noida authority has approved the launch of an ambitious entertainment theme based parks in four phases at the Great India Place (GIP) Mall in Sector 38-A.
Edit

Palatin Announces MC4R Agonist Bremelanotide Co-Administered with GLP-1/GIP Tirzepatide Meets Primary Endpoint in Phase 2 ...

Victoria Advocate 31 Mar 2025
Primary endpoint met in the 8-week treatment study (highly ...
Edit

Firm proposes theme park on 125 acres behind GIP on land allotted 23 years ago

The Times of India 31 Mar 2025
+Text SizeSmallMediumLarge. .
Edit

Palatin Announces MC4R Agonist Bremelanotide Co-Administered with GLP-1/GIP Tirzepatide Meets Primary Endpoint in Phase 2 Obesity Study

PR Newswire 31 Mar 2025
The data also showed that low dose MC4R agonist bremelanotide stopped the rapid weight regain seen after ending GLP-1/GIP tirzepatide treatment." ... following the discontinuation of GLP-1/GIP therapy.
Edit

The General Meeting approves a voluntary takeover bid to raise the free float with the support of Criteria, GIP, CVC, IFM and Sonatrach (Naturgy Energy Group SA)

Public Technologies 25 Mar 2025
The takeover bid has the backing of Naturgy's five key shareholders (Criteria, GIP, CVC, IFM and Sonatrach) ... María Isabel Gabarró for CriteriaCaixa; Martin Catchpole for GIP/BlackRock; Marta Martínez for Rioja/CVC; and Nicolás Villén for IFM.
Edit

The United Laboratories and Novo Nordisk announce exclusive license agreement for UBT251, a GLP-1/GIP/glucagon triple receptor agonist

Pharmiweb 25 Mar 2025
(United Biotechnology), have entered into an exclusive license agreement for UBT251, a triple agonist of the receptors for GLP-1, GIP, and glucagon in early-stage clinical development for the treatment of obesity, type 2 diabetes, and other diseases.
  • 1

Article Search

tools
×
×
×
×